Alain J. Gilbert - Profile and Investment Details

Investor Profile

Alain J. Gilbert is a Private Equity Firm, Investment Partner based in Paris, Île-de-France, France with a diverse investment portfolio that includes companies such as HighLife, CurvaFix, Aprea, F2G, Atea Pharmaceuticals, UNUM Therapeutics, Prilenia, Endosense, Cogent Biosciences, BioVex, Simplify Medical, Intellia Therapeutics, Checkmate Pharmaceuticals, Apellis Pharmaceuticals, REGENXBIO, Rainier Therapeutics, Pipeline Therapeutics, Effector Therapeutics, Advaxis, Shockwave Medical, RainDance Technologies, Viracta Therapeutics, Neuros Medical. Over time, Alain J. Gilbert has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Alain J. Gilbert is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Asset Management, Investment Management, Life Science, Emerging Markets, Biotech, Medical Device, Healthcare, Biotechnology, Clinical Trials, Medical, Real Estate, Therapeutics, Media and Entertainment, Personal Health, Pharmaceuticals, Biopharma may find it worthwhile to explore potential connections with Alain J. Gilbert, as their portfolio suggests a familiarity and interest in this area.

Understanding Alain J. Gilbert’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.